Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237.

Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237.

Human papilloma virus (HPV) is the main culprit in cervical cancers. Although the HPV vaccine is now available, the slow and gradual process for HPV cancers to form means little will change, even for vaccinated individuals. This warrants the development of new therapeutic strategies in both the newl...

Full description

Bibliographic Details
Main Authors: Yaman Tayyar, Ryan Shiels, Andrew C Bulmer, Alfred K Lam, Daniel Clarke, Adi Idris, Nigel A McMillan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0225774

Similar Items

Similar Items